X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Martin Shkreli (left), former Chief Executive Officer of Turing Pharmaceuticals, leaving the hearing room after appearing before the House Committee on Oversight and Government Reform during a hearing titled "Developments in the Prescription Drug Market," on February 4, 2016. Mr. Shkreli, on the advice of his attorney, Ben Brafman, right, of Brafman & Associates, refused to answer any questions. Photo by Diego M. Radzinschi/THE NATIONAL LAW JOURNAL. Martin Shkreli (left)) and his attorney Ben Brafman. (Photo: Diego M. Radzinschi/ALM)

If former pharmaceutical executive Martin Shkreli seeks to cure COVID-19, he can do so from prison, prosecutors argued Tuesday in their response to Shkreli’s motion for release in the Eastern District of New York.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 3 articles* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?

Jane Wester

Jane Wester is a litigation reporter for the New York Law Journal. Email her at jwester@alm.com or find her on Twitter @janewester.

More from this author

 

Health Care Fraud: Enforcement and ComplianceBook

Health Care Benefits Law explains how current laws affect the design and day-to-day administration of health care plans. It also helps you identify and deal with hid...

Get More Information
 
 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.